PI 3-Kinase p110 delta Antibody (PIK3CD/4639) [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-24232JF549
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry-Paraffin, Western Blot
Label
Janelia Fluor 549
Antibody Source
Monoclonal Mouse IgG2b Kappa Clone # PIK3CD/4639
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant fragment of human PI 3-Kinase p110 delta protein (around aa 520-720) (exact sequence is proprietary)
Localization
Cytoplasm.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2b Kappa
Applications for PI 3-Kinase p110 delta Antibody (PIK3CD/4639) [Janelia Fluor® 549]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PI 3-Kinase p110 delta
Long Name
Protein Tyrosine Phosphatase 1D
Alternate Names
PI 3Kinase p110 delta, PIK3CD
Gene Symbol
PIK3CD
Additional PI 3-Kinase p110 delta Products
Product Specific Notices for PI 3-Kinase p110 delta Antibody (PIK3CD/4639) [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...